1 Covid 19 Essay In Hindi Wikipedia Andhra Pradesh had received 370,000 doses of Covishield and 20,000 of Covaxin. The second dose was provided from 15 February onwards. According to India s Union Ministry of Health and Family Welfare, the most common side-effects include pain or swelling at the injection site, fever, irritability and headaches. 30 The company aims to produce 100 million doses per month, but by May 2021 its production capacity was only 60 70 million doses. Return to centralised procurement Edit. 139 Vaccination of people in the 18-44 age group with certain medical conditions began in early May, and that of all people in the 40-44 age group began on June 4. Phase 3 On 1 April 2021, all people above the age of 45 are now eligible in this phase. This includes Health Minister KK Shailaja, 133 Chief Minister Pinarayi Vijayan, 134 state police chief Lokanath Behera, 135 former Chief Minister VS Achuthanandan 136 and Thiruvananthapuram District Collector Navajoth Khosa. 5 lakh Covishield doses on its own for the phase 3 immunization. 60 lakh health workers in Punjab will receive a COVID-19 vaccine in the first phase, after that frontline worker and then people over the age of 50 or with co-morbid conditions. 84 On 20 April 2021, Bharat Biotech announced that it had expanded its production capabilities for Covaxin to 700 million doses per-year. 0 Crores which will be open for bidding from 8 June to 22 June 2021. 54 On 3 June, the Ministry of Health and Family Welfare pre-ordered 300 million doses of a potential fourth vaccine, Corbevax, which is undergoing phase 3 clinical trials. The pace of immunization has picked up and there are more than 2. The state aims to vaccinate 32,000 people a day. In September 2020, India s Health minister Harsh Vardhan stated that the country planned to approve and begin distribution of a vaccine by the first quarter of 2021. Phase 1b Vaccination of the frontline worker including police, local bodies, disaster management, rural development and panchayats and revenue departments will be starting from 1 February 2021. These changes were intended to help expedite the availability of vaccines already in use in other countries. 177 Medical experts maintain that vaccines used are safe and their benefits outweigh the risks. However, on the first two days, only 61 and 47. COVID-19 vaccination in India. 293,706,832 people with at least one dose administered of Covaxin or Oxford AstraZeneca vaccine or Sputnik V 67,616,716 people have been fully vaccinated with both doses of Covaxin or Oxford AstraZeneca vaccine or Sputnik V 21 of the Indian population has received at least one dose. 52 53 On 25 May, India exceeded 200 million vaccine doses administered in total. However, the documentation had been completed only in 3500 cases. One person was admitted to hospital following complications regarding vaccine, but was later discharged. 78 79 The government ordered 21 million doses to be delivered by February, but the company said no indication of any further orders were given. 06 crores 26,69,33,878 5,67,29,419 32,36,63,297 27 5 Andaman and Nicobar Islands 3,80,581 1,45,019 16,306 1,61,325 38 4 Andhra Pradesh 4,95,77,103 1,19,58,636 29,10,171 1,48,68,807 24 6 Arunachal Pradesh 13,83,727 4,75,959 81,866 5,57,825 34 6 Assam 3,12,05,576 56,68,538 11,86,267 68,54,805 18 4 Bihar 10,40,99,452 1,09,79,659 19,86,711 1,29,66,370 11 2 Chandigarh 10,55,450 4,21,745 82,381 5,04,126 40 8 Chhattisgarh 2,55,45,198 74,57,184 14,68,963 89,26,147 29 6 Dadra and Nagar Haveli 3,43,709 1,63,092 15,656 1,37,685 47 5 Daman and Diu 2,43,247 1,83,618 17,309 2,00,927 75 7 Delhi 16,787,941 56,36,415 17,02,823 73,39,238 34 10 Goa 14,58,545 7,62,730 1,08,743 8,71,473 52 7 Gujarat 6,04,39,692 1,95,00,497 53,87,325 2,48,87,822 32 9 Haryana 2,53,51,462 71,66,208 13,07,304 84,73,512 28 5 Himachal Pradesh 68,64,602 30,25,895 4,71,889 34,97,784 44 7 Jammu and Kashmir 1,22,67,032 37,00,498 6,45,594 43,46,092 30 5 Jharkhand 3,29,88,134 56,40,980 10,28,742 66,69,722 17 3 Karnataka 6,10,95,297 1,81,96,699 35,54,331 1,78,47,653 30 6 Kerala 3,34,06,061 1,05,41,451 29,94,428 1,35,35,879 32 9 Ladakh 2,74,000 1,68,691 47,925 2,16,616 62 17 Lakshadweep 64,473 46,340 7,516 53,856 72 12 Madhya Pradesh 7,26,26,809 1,74,66,939 23,59,925 1,98,26,864 24 3 Maharashtra 11,23,74,333 2,51,45,226 60,14,297 3,11,59,523 22 5 Manipur 25,70,390 5,33,686 73,067 6,06,753 21 3 Meghalaya 29,66,889 5,87,788 76,522 6,64,310 20 3 Mizoram 10,97,206 4,97,356 53,240 4,10,438 45 5 Nagaland 19,78,502 4,07,669 54,869 4,62,538 21 3 Odisha 4,19,74,219 95,41,255 20,30,467 1,15,71,722 23 5 Puducherry 12,47,953 4,18,646 63,226 4,81,872 34 5 Punjab 2,77,43,338 60,30,088 9,78,243 70,08,331 22 4 Rajasthan 6,85,48,437 2,04,13,290 38,38,633 2,42,51,923 30 6 Sikkim 6,10,577 3,71,539 61,597 4,33,136 61 10 Tamil Nadu 7,21,47,030 1,25,36,293 24,86,780 1,50,23,073 17 3 Telangana 3,50,03,674 89,45,614 14,85,529 1,04,31,143 26 4 Tripura 36,73,917 18,99,649 5,74,902 24,74,551 52 16 Uttar Pradesh 19,98,12,341 2,61,54,182 43,25,246 3,04,79,428 13 2 Uttarakhand 1,00,86,292 34,43,234 7,71,457 42,14,691 34 8 West Bengal 9,12,76,115 1,63,82,716 47,46,182 2,11,28,898 18 5 Miscellaneous 17,35,385 15,17,666 32,53,051 As of June 28, 2021 7 00 AM IST 120. 174 The state government had procured one lakh Covaxin doses and 3. 81 In June 2020, it received DCGI approval to begin phase 1 and phase 2 trials on its vaccine, BBV152 trade name Covaxin. Sudhakar announced on 9 January that the state would be given 13. 131 After vaccinating 3. The remainder would be offered to individual states and pur- chased on the open market including private hospitals , which would be able to serve residents over the age of 18. Madhya Pradesh Edit. India initially approved the Oxford AstraZeneca vaccine manufactured under license by Serum Institute of India under the trade name Covishield and Covaxin a vaccine developed locally by Bharat Biotech. 17 billion more vaccine doses from August to December 2021. Bihar received 569,000 doses of the vaccine. Uttar Pradesh was the first state to vaccinate over 20 lakh people. 8 The first recipients were to be 30 million health workers directly dealing with COVID patients. Reddy s Laboratories stated that it planned to have the vaccine available in India by late-May 2021. They have since been joined by the Sputnik V manufactured under license by Dr. 17 Each vaccination centre will offer either Covishield or Covaxin, but not both. 14,883 health workers in Maharashtra given COVID-19 vaccine on Tuesday 147 In Mumbai, only 1,926 people could be vaccinated on the first day, due to a combination of low turnout and technical problems with the software. Please note that this data is interim, so, the information is subject to change as per new official updates from health officials. 92 93 In April 2021, RDIF CEO Kirill Dmitriev told NDTV that they had five great manufacturers in India who would be producing the vaccine, and felt that the country could become Sputnik V s production hub for use and export. 142 Other States such as Karnataka have launched similar efforts which have garnered little success. Maharashtra Edit. 162 In a review meeting held in January 2021 by the state government, the state head of World Health Organization said that Rajasthan is the best state in terms of preparation for COVID vaccination. 45 46 47 An estimated 156 million doses is expected between August and December; initially, doses will be sourced from Russia, but domestic production is expected to begin by August 2021. There were two cases of adverse events, but neither required hospitalization. 76 The SII planned to manufacture 1. Hyderabad-based Bharat Biotech, in collaboration with U. Graph of daily doses administered across the country Edit. Uttar Pradesh Edit. The vaccination drive was temporarily suspended due to the technical glitches in the software alerting people to their vaccination appointments.